Delay Enables Monopoly: How Inaction in the Opposition Proceedings at the Patent Office Undermines Access to Medicines

/ By / Patent

What happens when patent oppositions are filed, heard, but never decided? Highlighting the specific instances of prolonged delays at the Patent Office, Prathibha Sivasubramanian explains how administrative inaction is undermining a critical safeguard in patent law and how such delays can quietly enable monopolies and impact access to essential medicines. Prathibha Sivasubramanian is a Senior Researcher working with TWN. She has over a decade of experience in access to medicines, patents, and intellectual property. She has worked extensively on patent […]

Delay Enables Monopoly: How Inaction in the Opposition Proceedings at the Patent Office Undermines Access to Medicines Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (30.03.2025)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: Fair Dealing Some bells do not just chime, they make space. This week’s bell is for Fair Dealing, a provision within the Copyright Act that enables much of how we read, write, teach and engage with creative works. Unlike

SpicyIP Bells & Whistles: IP Events and Opportunities (30.03.2025) Read More »

The GUI Verdict: A Celebration of Progress, or a Lament for Leadership?

/ By / Design

The Calcutta High Court’s decision in NEC Corporation marks a significant step forward for GUI design protection in India. However, beyond the celebration surrounding this development, Sachin Sharma points out that a more uncomfortable question remains—why did it take judicial intervention for this shift to occur at all? Sachin is an Associate Advocate at Sanghi & Co. An alumnus of NLU Delhi (LLM in IPR Law and Management), he is currently advancing his technical acumen through a BSc in Biotechnology.

The GUI Verdict: A Celebration of Progress, or a Lament for Leadership? Read More »

Let’s IPsa Loquitur: a Quick Rundown of the Major IP Developments from 2025

/ By / Trademark

In the latest episode of Let’s IPsa Loquitur, I sat down with Sonisha, Tanishka, Kartikeya, Kartik, Ambika, Malobika, and Bharathwaj for a quick rundown of the major IP developments from 2025. In Part 1 of this three-part discussion, we go over the key Trademark Developments, featuring orders that made headlines and stood out for their jurisprudential rigour. We also discuss important policy-related developments, along with other updates that do not fall within these categories. Readers can check it out below:-

Let’s IPsa Loquitur: a Quick Rundown of the Major IP Developments from 2025 Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 23 – March 29)

/ By / Copyright, Design, Others, Patent, Trademark

Almost at the end of March with a post on the wonder drug Semaglutide’s patent expiry and its impact in India. Post on the Calcutta HC’s judgment removing subject-matter objections to the registration of GUIs as a design under the Designs Act. Another post on the government-led blocking of 3100+ Telegram channels marking a significant shift in India’s intermediary liability regime and censorship architecture. Case summaries and IP developments from the country and the globe and much more in this

SpicyIP Weekly Review (March 23 – March 29) Read More »

The Madras High Court’s Injunction in Sreedevi v. SaReGaMa: Was the Supreme Court Right to Stay It?

/ By / Copyright

In Sreedevi Video Corporation v. SaReGaMa India Ltd., the Madras High Court took the unusual step of allowing an injunction claim to proceed even after holding the plaintiff’s claim to copyright ownership as time-barred. The Supreme Court has since stayed this ruling, signalling concerns with this separation of remedies. Shubham Thakare examines whether an injunction can truly survive a limitation bar on ownership, and the broader implications for copyright disputes under the Copyright Act and limitation law.  Shubham is a

The Madras High Court’s Injunction in Sreedevi v. SaReGaMa: Was the Supreme Court Right to Stay It? Read More »

A New Shield for the “Strike” Era? Analysing the Delhi High Court’s Reasoning in Associated Broadcasting v. Google

/ By / Copyright

In Associated Broadcasting Company v. Google, the Delhi High Court offers a respite to content creators against copyright strikes through Section 60 of the Copyright Act, 1957. Shubham Thakare explains the decision and how it provides creators with a meaningful, if limited, tool to challenge abusive copyright strikes. Shubham is a third-year B.A., LL.B. (Hons.) student at the National Law School of India University, Bengaluru, with an interest in copyright and trademark law. A New Shield for the “Strike” Era?

A New Shield for the “Strike” Era? Analysing the Delhi High Court’s Reasoning in Associated Broadcasting v. Google Read More »

Sahyog or Suppression? The New Architecture of Intermediary Liability

/ By / Others

The recent government-led blocking of 3100+ Telegram channels marks a significant shift in India’s intermediary liability regime and censorship architecture. Priyam Mitra examines how this move and the newly created Sahyog Platform erode due process and free speech safeguards. Priyam is a third-year student at NLSIU, Bengaluru, and is deeply interested in IP and Data Protection laws. His previous posts can be accessed here. Sahyog or Suppression? The New Architecture of Intermediary Liability By Priyam Mitra Telegram has been the subject

Sahyog or Suppression? The New Architecture of Intermediary Liability Read More »

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz

/ By / Patent, Trademark

Yesterday, Khushi and I wrote on the Semaglutide patent expiry and what it could mean for Indian generic companies and the general public. And while the market is seeing more affordable versions of the drug, a separate story is taking place in the Delhi High Court with Novo Nordisk filing a fresh set of trademark and patent infringement suits against generic companies.  The Ozempic Name Game: Novo Nordisk v. DRL Round 2 On Semaglutide injections, Novo Nordisk has filed a

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz Read More »

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India

/ By / Patent

[This post is co-authored with Khushi Krishania. Khushi is a third-year B.Sc. LL.B. (Hons.) {Cybersecurity} student at the National Law Institute University, Bhopal, with a particular interest in the intersection of copyright and data protection law.] Christmas came early for Indian generic manufacturers as the Indian patent on Semaglutide, a potent GLP-1 receptor agonist, expired on March 20. The drug is commercially sold by Novo Nordisk as Ozempic and Wegovy and is used to manage type-2 diabetes and obesity. After

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India Read More »

Scroll to Top